Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Taste Disorder, Secondary”

5 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 5 of 5 results

Very early researchStudy completedNCT04629560
What this trial is testing

Miracle Fruit Powder for the Treatment of Taste Alterations Secondary to Chemotherapy

Who this might be right for
Taste, AlteredDysgeusia
Mt. Sinai Medical Center, Miami 48
Not applicableWithdrawnNCT05760079
What this trial is testing

Lactoferrin for COVID-19-Induced Taste or Smell Abnormality

Who this might be right for
Covid19Taste Disorder, SecondaryTaste Disorders+4 more
Wake Forest University Health Sciences
Early research (Phase 1)Study completedNCT01302574
What this trial is testing

Role of the Gut Sweet Taste Receptor in the Secretion of Satiation Peptides

Who this might be right for
Taste Disorder, Secondary, Sweet
University Hospital, Basel, Switzerland 16
Early research (Phase 1)UnknownNCT05104424
What this trial is testing

The Study of Quadruple Therapy Intranasal Insulin, Zinc, Gabapentin, Ice Cube Stimulation for Post COVID-19 Smell and Taste Dysfunctions

Who this might be right for
Smell DysfunctionTaste DisordersTaste Disorder, Secondary, Sweet+2 more
Ministry of Health, Saudi Arabia 22
Not applicableLooking for participantsNCT07258563
What this trial is testing

The TASTY-steering Study

Who this might be right for
Metastatic Triple Negative Breast Cancer or Metastatic Testicular Cancer, or Stage II-IV Diffuse Large B Cell Lymphoma
University Medical Center Groningen 201